Search
Search Results
-
[11C]Choline PET/CT in a Patient with Prostate Cancer Biochemical Recurrence Showing Two Suspicious Findings in the Breast and Liver
A 79-year-old man with prostate cancer (PCa) was referred to our center to perform a [ 11 C]Choline PET/CT for biochemical recurrence. Positron...
-
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy
PurposeConditional survival represents the probability of subsequent survival given that patients have already survived a certain length of time....
-
The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer
PurposeTo assess whether completeness of pelvic lymph node dissection (PLND) as measured by lymph node yield reduces biochemical recurrence (BCR) in...
-
Clinical factors associated with biochemical recurrence of prostate cancer with seminal vesicle invasion followed by robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group)
Locally advanced prostate cancer (PCa) with pathological seminal vesicle invasion (pT3b) is a very-high-risk disease associated with biochemical...
-
Role of radiomic analysis of [18F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging
AimTo study the feasibility of radiomic analysis of baseline [ 18 F]fluoromethylcholine positron emission tomography/computed tomography (PET/CT) for...
-
Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis
ObjectivesTo systematically assess the early detection rate of biochemical prostate cancer recurrence using choline, fluciclovine, and PSMA.
...
-
Outcome comparison of radical prostatectomy versus seed brachytherapy for clinically localized prostate cancer using two biochemical recurrence definitions
ObjectiveWe compared the outcome of radical prostatectomy (RP) with seed brachytherapy (BT) in clinically localized prostate cancer (LPCa) using two...
-
Overweight and obesity as risk factors for biochemical recurrence of prostate cancer after radical prostatectomy
BackgroundPrevious studies have shown a relationship between the occurrence and recurrence of prostate cancer; however, this relationship remains...
-
Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing
BackgroundCancer-associated fibroblasts (CAFs) are an essential component of the tumor immune microenvironment that are involved in extracellular...
-
Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
PurposeThe prognostic value of PSMA intensity on PSMA PET/CT due to underlying biology and subsequent clinical implications is an emerging topic of...
-
Blood transfusion had no influence on the 5-year biochemical recurrence after robot-assisted radical prostatectomy: a retrospective study
BackgroundAlthough red blood cells (RBC) transfusion is known to be significantly associated with biochemical recurrence in patients undergoing open...
-
Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer
RationaleIn patients with biochemical recurrence of prostate cancer (BCR), preliminary data suggest that prostate-specific membrane antigen (PSMA)...
-
Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer
PurposeEarly biochemical recurrence (eBCR) indicated a high risk for potential recurrence and metastasis in prostate cancer. The N6-methyladenosine...
-
[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis
BackgroundThe state-of-the-art method for imaging men with biochemical recurrence of prostate cancer (BCR) is prostate-specific membrane antigen...
-
Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment
BackgroundProstate cancer (PCa) is the most prevalent genitourinary malignancy in men, with a significant proportion of patients develo**...
-
Risk factors for recurrence in pediatric urinary stone disease
BackgroundChildren’s urinary system stones may develop from environmental, metabolic, anatomical, and other causes. Our objective is to determine the...
-
Evaluation of Biochemical Recurrence and Correlation with Various Parameters After Robotic-Assisted Radical Prostatectomy: a Single Center Experience
IntroductionBiochemical recurrence (BCR) is widely used as an early end point to assess treatment success and frequently prompts the initiation of...
-
Does post prostatectomy decipher score predict biochemical recurrence and impact care?
PurposeTo examine the ability of the Decipher test to predict early biochemical recurrence after radical prostatectomy and to impact clinical...
-
Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patients
BackgroundIn this study, we investigated the ability of prostate-specific antigen (PSA) 12 months after (nPSA12) external beam radiotherapy (EBRT)...
-
Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging
PurposeIn this study, we evaluated the impact of 18 F-PSMA-11 PET/CT on the patient management plan in patients with primary or recurrent disease....
